#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome Cytomegalovirus infection Tourette's disorder Prostate cancer Liver transplant rejection Acute hepatic failure Hypertriglyceridaemia Infantile spasms Kearns-Sayre syndrome Chronic myelomonocytic leukaemia Uterine leiomyosarcoma Intracranial germ cell tumour Undifferentiated sarcoma Mantle cell lymphoma stage II B-cell small lymphocytic lymphoma refractory More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Trials in Disease Focal segmental glomerulosclerosis – Trials in Disease Thrombotic thrombocytopenic purpura – Treatment Ewing’s sarcoma metastatic – Treatment Ocular melanoma – Basic Information Methylmalonic acidaemia – Diagnostics Richter’s syndrome – Life with Disease Osteosarcoma recurrent – Life with Disease Brain stem glioma – Treatment Gaucher’s disease type I – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Terlipressin Acetate Ropeginterferon Alfa-2B Alxn1850 PETHIDINE HYDROCHLORIDE Lna043 Gemlapodect Ibuprofen AZD4360 Prednisone Acetate SAR443820 Evencaleucel Domvanalimab Berubicin Hydrochloride Cenerimod Meropenem Anhydrous Sparsentan Bendamustine Hydrochloride Cpk850 Acenocoumarol Pimecrolimus More therapies…

    Learn about Your Condition

    Hepatorenal syndrome Immune-mediated renal disorder Osteomyelitis Multiple sclerosis Congenital aplastic anaemia Retinal neovascularisation Endometrial adenocarcinoma Haemodialysis Glomerulonephritis chronic Chordoma Hodgkin's disease refractory Alcohol use disorder Acromegaly Lyme disease Lipid metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of doxecitine and doxribtimine oral solution for adult patients with Thymidine Kinase 2 (TK2) Deficiency

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mitochondrial myopathy
    Investigated Drugs:
    • Doxecitine
    • Doxribtimine
    Spain

  • Study on Norepinephrine for Improving Outcomes in Patients with Acute Progressive Stroke

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Noradrenaline Tartrate
    France

  • Study Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Fluocinolone Acetonide
    • Dexamethasone
    France

  • MRI Study with Hyperpolarized Pyruvate for Patients with Glioblastoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    • Neoplasm malignant
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on Reducing Anxiety in Children Undergoing Surgery: Comparing Midazolam and Tablet Distraction Techniques

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural anxiety
    Investigated Drugs:
    • Midazolam
    Belgium

  • Study on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Ifosfamide
    • Methotrexate
    France
Previous Page
1 … 522 523 524 525 526 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!